These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 21898068)

  • 1. Evaluation of the clinical efficacy of Biotène Oral Balance in patients with secondary Sjögren's syndrome: a pilot study.
    Aliko A; Alushi A; Tafaj A; Isufi R
    Rheumatol Int; 2012 Sep; 32(9):2877-81. PubMed ID: 21898068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A pilot study to test the efficacy of oral administration of interferon-alpha lozenges to patients with Sjögren's syndrome.
    Khurshudian AV
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2003 Jan; 95(1):38-44. PubMed ID: 12539025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A phase II study of Biotene in the treatment of postradiation xerostomia in patients with head and neck cancer.
    Warde P; Kroll B; O'Sullivan B; Aslanidis J; Tew-George E; Waldron J; Maxymiw W; Liu FF; Payne D; Cummings B
    Support Care Cancer; 2000 May; 8(3):203-8. PubMed ID: 10789961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the clinical efficacy of a mouthwash and oral gel containing the antimicrobial proteins lactoperoxidase, lysozyme and lactoferrin in elderly patients with dry mouth--a pilot study.
    Gil-Montoya JA; Guardia-López I; González-Moles MA
    Gerodontology; 2008 Mar; 25(1):3-9. PubMed ID: 18194332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of saliva substitute products in the treatment of dry mouth in the elderly: a pilot study.
    Matear DW; Barbaro J
    J R Soc Promot Health; 2005 Jan; 125(1):35-41. PubMed ID: 15712851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of GUM® Hydral versus Biotène® Oralbalance mouthwashes plus gels on symptoms of medication-induced xerostomia: a randomized, double-blind, crossover study.
    Barbe AG; Schmidt-Park Y; Hamacher S; Derman SHM; Noack MJ
    Clin Oral Investig; 2018 Jan; 22(1):169-180. PubMed ID: 28353023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Saliva substitute in xerostomic patients with primary Sjögren's syndrome: a single-blind trial.
    Alves MB; Motta AC; Messina WC; Migliari DA
    Quintessence Int; 2004 May; 35(5):392-6. PubMed ID: 15130080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of a mucoadhesive lipid-based bioerodable tablet compared with Biotène mouthwash for dry mouth relief--a pilot study.
    Aframian DJ; Mizrahi B; Granot I; Domb AJ
    Quintessence Int; 2010 Mar; 41(3):e36-42. PubMed ID: 20213013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized Controlled Trial of Rituximab and Cost-Effectiveness Analysis in Treating Fatigue and Oral Dryness in Primary Sjögren's Syndrome.
    Bowman SJ; Everett CC; O'Dwyer JL; Emery P; Pitzalis C; Ng WF; Pease CT; Price EJ; Sutcliffe N; Gendi NST; Hall FC; Ruddock SP; Fernandez C; Reynolds C; Hulme CT; Davies KA; Edwards CJ; Lanyon PC; Moots RJ; Roussou E; Giles IP; Sharples LD; Bombardieri M
    Arthritis Rheumatol; 2017 Jul; 69(7):1440-1450. PubMed ID: 28296257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of a new oral saliva equivalent in the management of xerostomia: a national, multicenter, randomized study.
    Salom M; Hachulla E; Bertolus C; Deschaumes C; Simoneau G; Mouly S
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2015 Mar; 119(3):301-9. PubMed ID: 25617119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double-blind, randomized, placebo-controlled study of cevimeline in Sjögren's syndrome patients with xerostomia and keratoconjunctivitis sicca.
    Petrone D; Condemi JJ; Fife R; Gluck O; Cohen S; Dalgin P
    Arthritis Rheum; 2002 Mar; 46(3):748-54. PubMed ID: 11920411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of rebamipide for the treatment of dry mouth symptoms in patients with Sjögren's syndrome: a double-blind placebo-controlled multicenter trial.
    Sugai S; Takahashi H; Ohta S; Nishinarita M; Takei M; Sawada S; Yamaji K; Oka H; Umehara H; Koni I; Sugiyama E; Nishiyama S; Kawakami A
    Mod Rheumatol; 2009; 19(2):114-24. PubMed ID: 19089532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subjective Assessment of Enamelon® Preventive Treatment Gel in a Self-Reported Dry-Mouth Population.
    Milleman JL; Milleman KR; Santos SL; Proskin HM; Battershell KK; DiMarino JC
    Compend Contin Educ Dent; 2016 Sep; 37(8):e5-8. PubMed ID: 27606566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Duration of effect of Biotène spray in patients with symptomatic dry mouth: A pilot study.
    Lung CB; Watson GE; Verma S; Feng C; Saunders RH
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2021 Apr; 131(4):415-421. PubMed ID: 33602603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficacy of Xialine in patients with Sjögren's syndrome: a single-blind, cross-over study.
    Alpöz E; Güneri P; Onder G; Cankaya H; Kabasakal Y; Köse T
    Clin Oral Investig; 2008 Jun; 12(2):165-72. PubMed ID: 18000691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association between oral dryness and use of dry-mouth interventions in Sjögren's syndrome patients.
    Assy Z; Bikker FJ; Picauly O; Brand HS
    Clin Oral Investig; 2022 Feb; 26(2):1465-1475. PubMed ID: 34374853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of the H2 receptor antagonist nizatidine on xerostomia in patients with primary Sjögren's syndrome.
    Kasama T; Shiozawa F; Isozaki T; Matsunawa M; Wakabayashi K; Odai T; Yajima N; Miwa Y; Negishi M; Ide H
    Mod Rheumatol; 2008; 18(5):455-9. PubMed ID: 18478182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of low-dose prednisolone maintenance for saliva production and serological abnormalities in patients with primary Sjögren's syndrome.
    Miyawaki S; Nishiyama S; Matoba K
    Intern Med; 1999 Dec; 38(12):938-43. PubMed ID: 10628930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Usefulness of oral pilocarpin therapy in the treatment of xerostomia and xerophthalmia in patients with primary Sjögren's syndrome].
    Solans R; Bosch JA; Selva A; Simeón CP; Fonollosa V; Vilardell M
    Med Clin (Barc); 2004 Feb; 122(7):253-5. PubMed ID: 15012873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined interventional sialendoscopy and intraductal steroid therapy for recurrent sialadenitis in Sjögren's syndrome: Results of a pilot monocentric trial.
    Capaccio P; Canzi P; Torretta S; Rossi V; Benazzo M; Bossi A; Vitali C; Cavagna L; Pignataro L
    Clin Otolaryngol; 2018 Feb; 43(1):96-102. PubMed ID: 28585263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.